Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,450,857
- Total 13F shares
- 46,131,357
- Share change
- +2,514,921
- Total reported value
- $1,868,819,935
- Put/Call ratio
- 0%
- Price per share
- $40.51
- Number of holders
- 204
- Value change
- +$92,954,236
- Number of buys
- 130
- Number of sells
- 78
Quarterly Holders Quick Answers
What is CUSIP 87650L103?
CUSIP 87650L103 identifies TARS - Tarsus Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87650L103:
Top shareholders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
13D/G
3/4/5
|
Company · 10%+ Owner |
8.1%
from 13D/G
|
3,316,032
|
$170,344,564 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.4%
from 13D/G
|
3,153,728
|
$162,007,007 | — | 31 Mar 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
6.1%
|
2,610,197
|
$134,085,820 | — | 31 Mar 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
5.9%
|
2,492,640
|
$128,046,917 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
5.8%
|
2,454,797
|
$126,102,922 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.2%
|
2,226,595
|
$114,380,186 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
4.7%
from 13D/G
|
2,012,777
|
$103,396,399 | — | 31 Mar 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
4.4%
|
1,874,745
|
$96,305,651 | — | 31 Mar 2025 | |
| Cowen Financial Products LLC |
13D/G
|
— |
4.9%
|
1,909,228
|
$94,926,816 | $0 | 31 Dec 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
3.5%
|
1,484,266
|
$76,246,744 | — | 31 Mar 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.3%
|
1,397,527
|
$71,790,962 | — | 31 Mar 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
3.1%
|
1,331,701
|
$68,409,000 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.7%
|
1,125,305
|
$57,806,918 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.3%
|
992,642
|
$50,992,020 | — | 31 Mar 2025 | |
| Vivo Capital IX, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,469,001
|
$49,380,020 | — | 05 May 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
910,716
|
$46,783,481 | — | 31 Mar 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2.1%
|
892,781
|
$45,862,000 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
865,434
|
$44,467,400 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.9%
|
826,523
|
$42,458,487 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.7%
|
717,853
|
$36,876,109 | — | 31 Mar 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.5%
|
653,743
|
$33,582,778 | — | 31 Mar 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1.4%
|
603,214
|
$30,987,103 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.2%
|
512,960
|
$26,522,597 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.2%
|
510,000
|
$26,198,700 | — | 31 Mar 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
1.1%
|
487,310
|
$25,033,115 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.1%
|
485,021
|
$24,915,528 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1%
|
433,171
|
$22,253,000 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
429,144
|
$22,045,127 | — | 31 Mar 2025 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.98%
|
416,811
|
$21,411,581 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.97%
|
410,676
|
$21,096,426 | — | 31 Mar 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.94%
|
400,000
|
$20,548,000 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.86%
|
363,432
|
$18,669,502 | — | 31 Mar 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.83%
|
354,376
|
$18,204,295 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.73%
|
308,230
|
$15,834,246 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.71%
|
301,510
|
$15,488,569 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.68%
|
290,318
|
$14,913,636 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.62%
|
264,523
|
$13,588,546 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.58%
|
247,195
|
$12,698,407 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.58%
|
246,844
|
$12,680,376 | — | 31 Mar 2025 | |
| Cutter Capital Management, LP |
13F
|
Company |
0.48%
|
205,000
|
$10,530,850 | — | 31 Mar 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.47%
|
200,000
|
$10,274,000 | — | 31 Mar 2025 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
0.42%
|
178,470
|
$9,168,004 | — | 31 Mar 2025 | |
| Sands Capital Alternatives, LLC |
13F
|
Company |
0.4%
|
170,000
|
$8,732,900 | — | 31 Mar 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.4%
|
168,721
|
$8,667,198 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.36%
|
151,421
|
$7,778,496 | — | 31 Mar 2025 | |
| Atika Capital Management LLC |
13F
|
Company |
0.34%
|
144,400
|
$7,417,828 | — | 31 Mar 2025 | |
| J. Goldman & Co LP |
13F
|
Company |
0.33%
|
140,288
|
$7,206,595 | — | 31 Mar 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.32%
|
134,617
|
$6,915,286 | — | 31 Mar 2025 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.31%
|
130,289
|
$6,692,946 | — | 31 Mar 2025 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.3%
|
127,932
|
$6,571,867 | — | 31 Mar 2025 |
Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) as of Q2 2025
As of 30 Jun 2025,
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) was held by
204 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,131,357 shares.
The largest 10 holders included
BlackRock, Inc., RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, JENNISON ASSOCIATES LLC, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, MORGAN STANLEY, JANUS HENDERSON GROUP PLC, Deep Track Capital, LP, and Frazier Life Sciences Management, L.P..
This page lists
204
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
191
Q2 2025 holders
204
Holder diff
13
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.